Corcept Therapeutics | CORT - PE Price to Earnings


Corcept Therapeutics reported 113.58 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
ANI Pharmaceuticals 27.31 10.68 Mar/2026
Aurora Cannabis 23.27 0 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Corcept Therapeutics 113.58 71.67 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
J&J 29.43 4.9 Jun/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Merck 16.52 2.6 Mar/2026
Novartis 20.17 2.32 Mar/2026
Novartis 21.36 3.57 Mar/2026
Pacira 38.58 14.1 Mar/2026
Pfizer 9.32 5.16 Mar/2026
Supernus Pharmaceuticals 44.21 66.17 Mar/2026
TG Therapeutics 10.76 2.32 Dec/2025